Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,284 | 86 | 79.2% |
| Travel and Lodging | $1,126 | 5 | 20.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $1,609 | 12 | $0 (2024) |
| Allergan, Inc. | $781.14 | 13 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $760.72 | 10 | $0 (2020) |
| CooperVision Inc. | $264.74 | 4 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $259.94 | 5 | $0 (2024) |
| ABBVIE INC. | $239.36 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $232.83 | 12 | $0 (2023) |
| Shire North American Group Inc | $218.02 | 10 | $0 (2018) |
| Johnson & Johnson Vision Care, Inc. | $146.45 | 2 | $0 (2018) |
| LKC Technologies, Inc. | $137.05 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $717.33 | 12 | ABBVIE INC. ($189.69) |
| 2023 | $665.70 | 12 | Bausch & Lomb Americas Inc. ($245.46) |
| 2022 | $272.31 | 6 | Alcon Vision LLC ($117.65) |
| 2021 | $167.45 | 9 | Allergan, Inc. ($113.24) |
| 2020 | $147.19 | 6 | Novartis Pharmaceuticals Corporation ($112.88) |
| 2019 | $2,133 | 22 | Alcon Vision LLC ($1,295) |
| 2018 | $745.04 | 12 | Bausch & Lomb, a division of Bausch Health US, LLC ($372.72) |
| 2017 | $562.04 | 12 | Allergan Inc. ($247.01) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Alcon Vision LLC | TOTAL30 (Device), DAILIES TOTAL1, Precision 1 | Food and Beverage | In-kind items and services | $118.46 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: EYE CARE | ||||||
| 10/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: EYE CARE | ||||||
| 09/19/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $115.42 | General |
| Category: EYE CARE | ||||||
| 09/04/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: SOLUTION/ DROPS | ||||||
| 08/01/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: EYE CARE | ||||||
| 06/04/2024 | LKC Technologies, Inc. | — | Food and Beverage | In-kind items and services | $137.05 | General |
| 04/04/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Ophthalmology | ||||||
| 03/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: EYE CARE | ||||||
| 03/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: EYE CARE | ||||||
| 02/08/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $116.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/11/2023 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Ophthalmology | ||||||
| 11/29/2023 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Ophthalmology | ||||||
| 11/10/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: EYE CARE | ||||||
| 10/26/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $107.98 | General |
| Category: Ophthalmology | ||||||
| 10/03/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: EYE CARE | ||||||
| 08/03/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: EYE CARE | ||||||
| 06/27/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Ophthalmology | ||||||
| 05/02/2023 | Sight Sciences, Inc. | TEARCARE SYSTEM (Device) | Food and Beverage | In-kind items and services | $114.97 | General |
| Category: Ophthalmology | ||||||
| 04/19/2023 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $108.56 | General |
| 03/29/2023 | CooperVision Inc. | MiSight Contact Lens (Device) | Food and Beverage | In-kind items and services | $111.91 | General |
| Category: Devices | ||||||
| 03/29/2023 | CooperVision Inc. | Biofinity Contact Lens (Device) | Food and Beverage | In-kind items and services | $45.45 | General |
| Category: Devices | ||||||
| 03/08/2023 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $77.52 | General |
| Category: Ophthalmology | ||||||
| 10/04/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 249 | 274 | $45,670 | $19,146 |
| 2022 | 5 | 258 | 305 | $49,295 | $20,347 |
| 2021 | 7 | 290 | 315 | $50,475 | $22,447 |
| 2020 | 5 | 308 | 350 | $50,690 | $23,817 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 79 | 79 | $13,825 | $6,643 | 48.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 81 | 102 | $15,300 | $5,865 | 38.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 49 | 49 | $12,250 | $4,779 | 39.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 19 | $1,520 | $824.87 | 54.3% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 11 | 11 | $1,375 | $600.30 | 43.7% |
| 92134 | Imaging of retina | Office | 2023 | 13 | 14 | $1,400 | $433.18 | 30.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 97 | 99 | $17,325 | $7,274 | 42.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 63 | 105 | $15,750 | $6,270 | 39.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 63 | 63 | $13,300 | $5,576 | 41.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 25 | $1,620 | $965.42 | 59.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 13 | 13 | $1,300 | $260.98 | 20.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 120 | 120 | $21,000 | $9,820 | 46.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 74 | 74 | $14,800 | $6,748 | 45.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 40 | 62 | $9,300 | $3,938 | 42.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 16 | 19 | $1,100 | $624.12 | 56.7% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 11 | 11 | $1,375 | $481.39 | 35.0% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 14 | 14 | $1,400 | $424.19 | 30.3% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 15 | 15 | $1,500 | $411.84 | 27.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 129 | 129 | $21,750 | $10,636 | 48.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 63 | 94 | $13,340 | $5,889 | 44.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 60 | 60 | $11,500 | $5,236 | 45.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 41 | 52 | $2,600 | $1,604 | 61.7% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 15 | 15 | $1,500 | $451.38 | 30.1% |
About Dr. Sonia Silva, OD
Dr. Sonia Silva, OD is a Optometrist healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861503054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonia Silva, OD has received a total of $5,410 in payments from pharmaceutical and medical device companies, with $717.33 received in 2024. These payments were reported across 91 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,284).
As a Medicare-enrolled provider, Silva has provided services to 1,105 Medicare beneficiaries, totaling 1,244 services with total Medicare billing of $85,757. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Weslaco, TX
- Active Since 08/31/2006
- Last Updated 04/06/2017
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1861503054
Products in Payments
- DAILIES (Device) $1,345
- XIIDRA (Drug) $494.25
- LUMIGAN (Drug) $401.24
- VYZULTA (Drug) $391.91
- DURYSTA (Drug) $217.11
- TOTAL30 (Device) $195.98
- RESTASIS (Drug) $163.48
- Acuvue (Device) $146.45
- OXERVATE (Drug) $125.00
- RXSIGHT CONTACT LENS (Device) $116.97
- TEARCARE SYSTEM (Device) $114.97
- MiSight Contact Lens (Device) $111.91
- Rhopressa (Drug) $110.40
- BESIVANCE (Drug) $109.46
- MIEBO (Drug) $107.98
- Multiple Brands Contact Lens (Device) $107.38
- LUMIZYME (Drug) $100.00
- LOTEMAX SM (Drug) $95.66
- ZYLET (Drug) $83.43
- LOTEMAX GEL (Drug) $82.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Weslaco
Dr. Jaime Rodriguez, O.d, O.D
Optometrist — Payments: $5,172
Dr. Dennis Chang, O.d, O.D
Optometrist — Payments: $4,551
Dr. Cassandra Cavazos-Salazar, O.d, O.D
Optometrist — Payments: $3,052
Terry Taylor, O.d, O.D
Optometrist — Payments: $2,327
Miriam Almanza, Od, OD
Optometrist — Payments: $820.68
Mrs. Brenda Fadeyi, O.d, O.D
Optometrist — Payments: $784.60